MedPath
NMPA Approval

Bimatoprost Ophthalmic Solution

国药准字H20244892

October 15, 2024

Drug Information

贝美前列素滴眼液

眼用制剂

0.03%(0.4ml:0.12mg)

化学药品

October 15, 2024

Company Information

Applicant Company

广州市南沙区珠江工业园美德三路1号自编A区5层501房

Manufacturing Company

广州市南沙区珠江工业园美德三路1号自编B栋5楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

贝美前列素滴眼液 - NMPA 批准文号 | MedPath